Literature DB >> 26212951

Iron binding to caseins in the presence of orthophosphate.

V A Mittal1, A Ellis1, A Ye1, P J B Edwards2, S Das1, H Singh3.   

Abstract

As adding >5mM ferric chloride to sodium caseinate solutions results in protein precipitation, the effects of orthophosphate (0-64 mM) addition to sodium caseinate solution (2% w/v protein) on iron-induced aggregation of the caseins were studied at pH 6.8. Up to 20mM ferric chloride could be added to sodium caseinate solution containing 32 mM orthophosphate without any protein precipitation. The addition of iron to sodium caseinate solution containing orthophosphate reduced the diffusible phosphorus content in a concentration-dependent manner. Added iron appeared to interact simultaneously with phosphoserine on the caseins and inorganic phosphorus. The relative sizes of the casein aggregates were governed by the concentration of orthophosphate and the aggregates consisted of all casein fractions, even at the lowest level of ferric chloride addition (5mM). It is hypothesised that the addition of iron to caseins in the presence of orthophosphate results in the formation of colloidal structures involving casein-iron-orthophosphate interactions.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Acetone (PubChem CID:180); Beta-mercaptoethanol (PubChem CID:1567); Brilliant blue (PubChem CID:19700); Casein; Deuterium oxide (PubChem CID:24602); Di-potassium hydrogen orthophosphate (PubChem CID:16217523); Ferric chloride hexahydrate (PubChem CID:24810); Glacial acetic acid (PubChem CID:176); Immidazole (PubChem CID:795); Iron; Orthophosphate; Phosphoserine; Propanol (PubChem CID:1031); Sodium hydroxide (PubChem CID:14798); Solubility; Triphenulphosphine (PubChem CID:11776)

Mesh:

Substances:

Year:  2015        PMID: 26212951     DOI: 10.1016/j.foodchem.2015.05.066

Source DB:  PubMed          Journal:  Food Chem        ISSN: 0308-8146            Impact factor:   7.514


  3 in total

1.  Iron bioavailability of a casein-based iron fortificant compared with that of ferrous sulfate in whole milk: a randomized trial with a crossover design in adult women.

Authors:  Sharon J Henare; Nadia Nur Singh; Ashling M Ellis; Paul J Moughan; Abby K Thompson; Thomas Walczyk
Journal:  Am J Clin Nutr       Date:  2019-12-01       Impact factor: 7.045

2.  Safety of iron milk proteinate as a novel food pursuant to Regulation (EU) 2015/2283 and bioavailability of iron from this source in the context of Directive 2002/46/EC.

Authors:  Dominique Turck; Jacqueline Castenmiller; Stefaan De Henauw; Karen Ildico Hirsch-Ernst; Alexandre Maciuk; Inge Mangelsdorf; Harry J McArdle; Androniki Naska; Carmen Pelaez; Kristina Pentieva; Alfonso Siani; Frank Thies; Sophia Tsabouri; Marco Vinceti; Francesco Cubadda; Thomas Frenzel; Marina Heinonen; Miguel Prieto Maradona; Rosangela Marchelli; Monika Neuhäuser-Berthold; Morten Poulsen; Josef Rudolf Schlatter; Henk van Loveren; Reinhard Ackerl; Helle Katrine Knutsen
Journal:  EFSA J       Date:  2022-09-16

3.  Impact of Ascorbic Acid on the In Vitro Iron Bioavailability of a Casein-Based Iron Fortificant.

Authors:  Magalie Sabatier; Andreas Rytz; Joeska Husny; Stéphane Dubascoux; Marine Nicolas; Anant Dave; Harjinder Singh; Mary Bodis; Raymond P Glahn
Journal:  Nutrients       Date:  2020-09-11       Impact factor: 5.717

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.